Will The Inflation Reduction Act Really Cut Drug Prices?

CareTalk Podcast

Will The Inflation Reduction Act Really Cut Drug Prices?

October 25, 2022

Will The Inflation Reduction Act Really Cut Drug Prices?

The Inflation Reduction Act of 2022, signed into law by President Biden in August, includes several provisions to lower prescription drug costs for people with Medicare and reduce drug spending by the federal government. What are the provisions? How will it impact healthcare? And why is big Pharma pushing back?
(1:49) What are the prescription drug provisions of the Inflation Reduction Act?
(9:26) Why is pharma upset about the Inflation Reduction Act?
(12:18) Is innovation threatened by US drug pricing control?
(14:50) What is the potential healthcare impact of the Inflation Reduction Act?

CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.



You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

Proudly supported by:

Nashville’s Opportunity: Eco-Action or Anxiety In this excerpt from a Climate x Health Twitter Spaces live chat, experts from Vanderbilt, Oak Ridge National Laboratory, and others discuss hope and want listeners to be energetic and reject “doomerism” while embracing reality and emphasizing teamwork without ego to accomplish individual and systemic goals. This conversation was hosted live from the AAMC conference in Nashville.